ARGX

argenx (ARGX)

argenx SE

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARGX

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Date	Time	Source	Headline	Symbol	Company
07/29/2022	8:38AM	TipRanks	Morgan Stanley Believes Argenx Se (ARGX) Still Has Room to Grow	NASDAQ:ARGX	argenx SE
07/29/2022	8:38AM	TipRanks	H.C. Wainwright Believes Argenx Se (ARGX) Still Has Room to Grow	NASDAQ:ARGX	argenx SE
07/29/2022	12:13AM	TipRanks	SVB Securities Believes Argenx Se (ARGX) Won’t Stop Here	NASDAQ:ARGX	argenx SE
07/28/2022	8:43AM	TipRanks	JMP Securities Reiterates a Buy Rating on Argenx Se (ARGX)	NASDAQ:ARGX	argenx SE
07/28/2022	8:30AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ARGX	argenx SE
07/28/2022	2:30AM	GlobeNewswire Inc.	argenx announces Extraordinary General Meeting of Shareholders on September 8, 2022	NASDAQ:ARGX	argenx SE
07/28/2022	1:00AM	GlobeNewswire Inc.	argenx Reports Half Year 2022 Financial Results and Provides Second Quarter Business Update	NASDAQ:ARGX	argenx SE
07/21/2022	1:00AM	GlobeNewswire Inc.	argenx to Report Half Year 2022 Financial Results and Second Quarter Business Update on July 28, 2022	NASDAQ:ARGX	argenx SE
06/27/2022	6:15AM	TipRanks	H.C. Wainwright Believes Argenx Se (ARGX) Still Has Room to Grow	NASDAQ:ARGX	argenx SE
06/24/2022	1:00AM	GlobeNewswire Inc.	argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europe	NASDAQ:ARGX	argenx SE
06/01/2022	1:00AM	GlobeNewswire Inc.	argenx to Present at Upcoming Investor Conferences	NASDAQ:ARGX	argenx SE
05/31/2022	1:00AM	GlobeNewswire Inc.	argenx Announces the UK MHRA has Granted Early Access to Efgartigimod for Generalized Myasthenia Gravis	NASDAQ:ARGX	argenx SE
05/24/2022	10:36PM	TipRanks	Argenx Se (ARGX) Initiated with a Buy at SVB Securities	NASDAQ:ARGX	argenx SE
05/19/2022	4:32PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ARGX	argenx SE
05/19/2022	7:00AM	GlobeNewswire Inc.	argenx Announces Publication of Translational Data of Efgartigimod in Autoimmune Skin Blistering Diseases	NASDAQ:ARGX	argenx SE
05/10/2022	5:30PM	GlobeNewswire Inc.	argenx announces results of Annual General Meeting of Shareholders	NASDAQ:ARGX	argenx SE
05/07/2022	8:18AM	TipRanks	J.P. Morgan Keeps a Buy Rating on Argenx Se (ARGX)	NASDAQ:ARGX	argenx SE
05/06/2022	11:31PM	TipRanks	Argenx Se (ARGX) Receives a Buy from Robert W. Baird	NASDAQ:ARGX	argenx SE
05/06/2022	6:15AM	TipRanks	H.C. Wainwright Remains a Buy on Argenx Se (ARGX)	NASDAQ:ARGX	argenx SE
05/05/2022	8:06PM	TipRanks	JMP Securities Reiterates a Buy Rating on Argenx Se (ARGX)	NASDAQ:ARGX	argenx SE
05/05/2022	7:53AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ARGX	argenx SE
05/05/2022	1:00AM	GlobeNewswire Inc.	argenx Reports First Quarter 2022 Financial Results and Provides Business Update	NASDAQ:ARGX	argenx SE
05/05/2022	1:00AM	GlobeNewswire Inc.	argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia	NASDAQ:ARGX	argenx SE
05/04/2022	1:00AM	GlobeNewswire Inc.	argenx to Present at BofA Securities 2022 Healthcare Conference	NASDAQ:ARGX	argenx SE
04/28/2022	1:00AM	GlobeNewswire Inc.	argenx to Report First Quarter 2022 Financial Results and Business Update on May 5, 2022	NASDAQ:ARGX	argenx SE
04/05/2022	1:00AM	GlobeNewswire Inc.	argenx Presents Interim Results from ADAPT+ Open-Label Extension Study Evaluating VYVGART® (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis at 2022 AAN Annual Meeting	NASDAQ:ARGX	argenx SE
04/01/2022	1:00AM	Business Wire	argenx to Present New Data from Generalized Myasthenia Gravis Program at 2022 American Academy of Neurology Annual Meeting	NASDAQ:ARGX	argenx SE
03/29/2022	5:00PM	GlobeNewswire Inc.	argenx announces full exercise of underwriters’ option to purchase additional ADSs	NASDAQ:ARGX	argenx SE
03/29/2022	4:30PM	GlobeNewswire Inc.	argenx announces Annual General Meeting of Shareholders on May 10, 2022	NASDAQ:ARGX	argenx SE
03/28/2022	4:30PM	GlobeNewswire Inc.	argenx announces closing of global offering	NASDAQ:ARGX	argenx SE